Join Now

bioMérieux Recognized as Top 1% by S&P Global

bioMérieux Recognized as Top 1% by S&P Global

Posted in BioUtah News | Tagged | Comments Off on bioMérieux Recognized as Top 1% by S&P Global

bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid

bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid

Posted in BioUtah News | Tagged | Comments Off on bioMérieux receives U.S. FDA clearance for the new version of its molecular test targeting causes of gastroenteritis, BIOFIRE® FILMARRAY® Gastrointestinal (GI) Panel Mid

BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance

BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance

Posted in BioUtah News | Tagged , | Comments Off on BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance

UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

Representatives John Curtis (R-UT) and Blake Moore (R-UT) toured bioMérieux.

Posted in Policy News | Tagged | Comments Off on UTAH REPS. CURTIS AND MOORE TOUR BIOMERIEUX

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance

Posted in BioUtah News | Tagged | Comments Off on Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance

Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

Posted in BioUtah News | Tagged | Comments Off on Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® R/ST Panel

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

Posted in BioUtah News | Tagged | Comments Off on bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

Posted in BioUtah News | Tagged | Comments Off on bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

Why Antimicrobial Resistance Is Top of bioMérieux’s Diagnostic List

CLP Magazine recently interviewed Kristen Smith, senior medical science liaison at bioMérieux

Posted in BioUtah News | Tagged | Comments Off on Why Antimicrobial Resistance Is Top of bioMérieux’s Diagnostic List

bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).

Posted in BioUtah News | Tagged | Comments Off on bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System and its BIOFIRE® SPOTFIRE® Respiratory (R) Panel

US FDA 510(k) Clearance and CLIA-waiver for the fast and innovative BIOFIRE® SPOTFIRE® System

Posted in BioUtah News | Tagged | Leave a comment

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®

Posted in BioUtah News | Tagged | Leave a comment